세계의 능동 이식형 의료기기 시장

Global Active Implantable Medical Devices Market to Reach US$51.3 Billion by 2030

The global market for Active Implantable Medical Devices estimated at US$30.5 Billion in the year 2023, is expected to reach US$51.3 Billion by 2030, growing at a CAGR of 7.7% over the analysis period 2023-2030. Implantable Cardioverter Defibrillators, one of the segments analyzed in the report, is expected to record a 7.9% CAGR and reach US$17.2 Billion by the end of the analysis period. Growth in the Implantable Cardiac Pacemakers segment is estimated at 8.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$8.4 Billion While China is Forecast to Grow at 7.3% CAGR

The Active Implantable Medical Devices market in the U.S. is estimated at US$8.4 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$7.9 Billion by the year 2030 trailing a CAGR of 7.3% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.2% and 6.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.2% CAGR.

Global Active Implantable Medical Devices Market - Key Trends and Drivers Summarized

Why Are Active Implantable Medical Devices Revolutionizing Healthcare?

Active implantable medical devices (AIMDs) have emerged as a game-changer in the healthcare industry, offering unprecedented solutions for managing chronic diseases and improving patient outcomes. These devices, which include pacemakers, defibrillators, neurostimulators, and cochlear implants, are designed to be implanted into the body to monitor, diagnose, and treat various medical conditions. The integration of advanced technologies in AIMDs has significantly enhanced their functionality, enabling continuous monitoring and real-time data transmission to healthcare providers. This capability not only allows for timely medical interventions but also reduces hospital readmissions and healthcare costs. The evolution of AIMDs represents a significant leap forward in personalized medicine, providing tailored treatments that cater to the specific needs of individual patients.

How Do Technological Advancements Boost AIMDs' Effectiveness?

Technological advancements have played a pivotal role in the development and effectiveness of AIMDs. The incorporation of microelectronics, wireless communication, and energy-efficient power sources has made these devices smaller, more reliable, and longer-lasting. Innovations in biocompatible materials have improved the safety and durability of implants, reducing the risk of adverse reactions and device failure. Moreover, the integration of artificial intelligence and machine learning algorithms enables AIMDs to adapt to the changing physiological conditions of patients, optimizing therapeutic outcomes. These technological strides not only enhance the performance of AIMDs but also expand their applications, making them suitable for a wider range of medical conditions. As a result, patients benefit from more effective and less invasive treatment options, leading to better quality of life and prolonged survival rates.

What Trends and Market Dynamics Are Influencing AIMDs?

The AIMD market is influenced by several emerging trends and market dynamics. The aging global population is a significant factor driving the demand for AIMDs, as the prevalence of chronic diseases such as cardiovascular disorders, neurological conditions, and hearing impairments increases with age. Additionally, the rise in lifestyle-related diseases, such as diabetes and obesity, has further escalated the need for advanced medical interventions. Regulatory frameworks and approval processes are becoming more stringent, ensuring the safety and efficacy of AIMDs, which in turn boosts patient confidence and adoption rates. Furthermore, advancements in telemedicine and remote monitoring technologies are complementing the functionality of AIMDs, enabling seamless connectivity between patients and healthcare providers. These trends underscore the growing importance of AIMDs in addressing the complex healthcare challenges of the modern world.

What Drives the Growth in the Active Implantable Medical Devices Market?

The growth in the active implantable medical devices market is driven by several factors. One of the primary drivers is the continuous technological innovation that enhances the capabilities and reliability of these devices. The increasing prevalence of chronic diseases and the growing aging population create a substantial demand for AIMDs. Moreover, the expanding healthcare infrastructure, particularly in emerging markets, provides significant growth opportunities for AIMD manufacturers. Patient awareness and acceptance of these devices are also on the rise, driven by successful clinical outcomes and extensive marketing efforts by medical device companies. Regulatory support and favorable reimbursement policies further accelerate market adoption. Additionally, the trend towards minimally invasive surgical procedures and the integration of AIMDs with digital health platforms for remote monitoring and management propel the market forward. These factors collectively contribute to the robust growth and dynamic evolution of the active implantable medical devices market, making it a critical component of modern healthcare delivery.

Select Competitors (Total 13 Featured) -

• Abbott Laboratories
• Biotronik SE & Co. KG
• Boston Scientific Corporation
• Cochlear Ltd.
• LivaNova PLC
• MED-EL Elektromedizinische Gerate Gesellschaft m.b.H.
• Medtronic PLC
• Nurotron Biotechnology Co., Ltd.
• Sonova AG
• William Demant Holding A/S

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • Global Economic Update
  • Active Implantable Medical Devices - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Increasing Prevalence of Chronic Diseases Spurs Demand for AIMDs
  • Aging Population Expands Addressable Market Opportunity for AIMDs
  • Technological Innovations Propel Growth in Active Implantable Medical Devices
  • Advances in Microelectronics Strengthen Business Case for AIMDs
  • Integration of AI and Machine Learning Accelerates Demand for Intelligent Implants
  • Enhanced Biocompatible Materials Drive Adoption of Safer AIMDs
  • Telemedicine and Remote Monitoring Technologies Propel Market Growth
  • Minimally Invasive Procedures Sustain Growth in AIMD Adoption
  • Expanding Healthcare Infrastructure in Emerging Markets Expands Market Opportunities
  • Innovations in Power Sources and Energy Efficiency Propel AIMD Advancements
  • Digital Health Integration Drives Demand for Connected AIMDs
  • Data Security and Privacy Concerns Create Challenges and Opportunities for AIMDs
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Recent Past, Current & Future Analysis for Active Implantable Medical Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 2: World Historic Review for Active Implantable Medical Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 3: World 16-Year Perspective for Active Implantable Medical Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
  • TABLE 4: World Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 5: World Historic Review for Implantable Cardioverter Defibrillators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 6: World 16-Year Perspective for Implantable Cardioverter Defibrillators by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 7: World Recent Past, Current & Future Analysis for Implantable Cardiac Pacemakers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 8: World Historic Review for Implantable Cardiac Pacemakers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 9: World 16-Year Perspective for Implantable Cardiac Pacemakers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 10: World Recent Past, Current & Future Analysis for Ventricular Assist Device by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 11: World Historic Review for Ventricular Assist Device by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 12: World 16-Year Perspective for Ventricular Assist Device by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 13: World Recent Past, Current & Future Analysis for Implantable Hearing Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 14: World Historic Review for Implantable Hearing Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 15: World 16-Year Perspective for Implantable Hearing Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 16: World Active Implantable Medical Devices Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Implantable Heart Monitors / Insertable Loop Recorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Implantable Heart Monitors / Insertable Loop Recorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 19: World 16-Year Perspective for Implantable Heart Monitors / Insertable Loop Recorders by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Neurostimulators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Neurostimulators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 22: World 16-Year Perspective for Neurostimulators by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Active Implantable Medical Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • TABLE 23: USA Recent Past, Current & Future Analysis for Active Implantable Medical Devices by Product - Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 24: USA Historic Review for Active Implantable Medical Devices by Product - Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 25: USA 16-Year Perspective for Active Implantable Medical Devices by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices for the Years 2014, 2024 & 2030
• CANADA
  • TABLE 26: Canada Recent Past, Current & Future Analysis for Active Implantable Medical Devices by Product - Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 27: Canada Historic Review for Active Implantable Medical Devices by Product - Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 28: Canada 16-Year Perspective for Active Implantable Medical Devices by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices for the Years 2014, 2024 & 2030
• JAPAN
  • Active Implantable Medical Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
  • TABLE 29: Japan Recent Past, Current & Future Analysis for Active Implantable Medical Devices by Product - Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 30: Japan Historic Review for Active Implantable Medical Devices by Product - Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 31: Japan 16-Year Perspective for Active Implantable Medical Devices by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices for the Years 2014, 2024 & 2030
• CHINA
  • Active Implantable Medical Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
  • TABLE 32: China Recent Past, Current & Future Analysis for Active Implantable Medical Devices by Product - Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 33: China Historic Review for Active Implantable Medical Devices by Product - Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 34: China 16-Year Perspective for Active Implantable Medical Devices by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices for the Years 2014, 2024 & 2030
• EUROPE
  • Active Implantable Medical Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • TABLE 35: Europe Recent Past, Current & Future Analysis for Active Implantable Medical Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 36: Europe Historic Review for Active Implantable Medical Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 37: Europe 16-Year Perspective for Active Implantable Medical Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
  • TABLE 38: Europe Recent Past, Current & Future Analysis for Active Implantable Medical Devices by Product - Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 39: Europe Historic Review for Active Implantable Medical Devices by Product - Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 40: Europe 16-Year Perspective for Active Implantable Medical Devices by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices for the Years 2014, 2024 & 2030
• FRANCE
  • Active Implantable Medical Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
  • TABLE 41: France Recent Past, Current & Future Analysis for Active Implantable Medical Devices by Product - Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 42: France Historic Review for Active Implantable Medical Devices by Product - Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 43: France 16-Year Perspective for Active Implantable Medical Devices by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices for the Years 2014, 2024 & 2030
• GERMANY
  • Active Implantable Medical Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
  • TABLE 44: Germany Recent Past, Current & Future Analysis for Active Implantable Medical Devices by Product - Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 45: Germany Historic Review for Active Implantable Medical Devices by Product - Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 46: Germany 16-Year Perspective for Active Implantable Medical Devices by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices for the Years 2014, 2024 & 2030
• ITALY
  • TABLE 47: Italy Recent Past, Current & Future Analysis for Active Implantable Medical Devices by Product - Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 48: Italy Historic Review for Active Implantable Medical Devices by Product - Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 49: Italy 16-Year Perspective for Active Implantable Medical Devices by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices for the Years 2014, 2024 & 2030
• UNITED KINGDOM
  • Active Implantable Medical Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
  • TABLE 50: UK Recent Past, Current & Future Analysis for Active Implantable Medical Devices by Product - Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 51: UK Historic Review for Active Implantable Medical Devices by Product - Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 52: UK 16-Year Perspective for Active Implantable Medical Devices by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices for the Years 2014, 2024 & 2030
• REST OF EUROPE
  • TABLE 53: Rest of Europe Recent Past, Current & Future Analysis for Active Implantable Medical Devices by Product - Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 54: Rest of Europe Historic Review for Active Implantable Medical Devices by Product - Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 55: Rest of Europe 16-Year Perspective for Active Implantable Medical Devices by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices for the Years 2014, 2024 & 2030
• ASIA-PACIFIC
  • Active Implantable Medical Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
  • TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Active Implantable Medical Devices by Product - Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 57: Asia-Pacific Historic Review for Active Implantable Medical Devices by Product - Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 58: Asia-Pacific 16-Year Perspective for Active Implantable Medical Devices by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices for the Years 2014, 2024 & 2030
• REST OF WORLD
  • TABLE 59: Rest of World Recent Past, Current & Future Analysis for Active Implantable Medical Devices by Product - Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 60: Rest of World Historic Review for Active Implantable Medical Devices by Product - Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 61: Rest of World 16-Year Perspective for Active Implantable Medical Devices by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices for the Years 2014, 2024 & 2030

IV. COMPETITION